Nirsevimab: The Hidden Costs

被引：4
|
作者：
Neumann, Samantha [1 ,2 ]
Alverson, Brian [1 ,2 ]
机构：
[1] Nemours Childrens Hlth, Wilmington, DE USA
[2] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA USA
来源：
HOSPITAL PEDIATRICS | 2024年 / 14卷 / 06期
关键词：
RESPIRATORY SYNCYTIAL VIRUS; INFANTS; RSV;
D O I：
10.1542/hpeds.2024-007739
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
[No abstract available]
引用
收藏
页码：e276 / e278
页数：3
相关论文
共 50 条
  • [1] The Nirsevimab
    Levien, Terri L.
    Baker, Danial E.
    HOSPITAL PHARMACY, 2024, 59 (02) : 138 - 145
  • [2] Nirsevimab: A Review
    Balbi, Howard
    PEDIATRIC ALLERGY IMMUNOLOGY AND PULMONOLOGY, 2024, 37 (01) : 3 - 6
  • [3] Balanced on the Biggest Wave: Nirsevimab for Newborns
    McPherson, Christopher
    Lockowitz, Christine R.
    Newland, Jason G.
    NEONATAL NETWORK, 2024, 43 (02): : 105 - 115
  • [4] Nirsevimab: First Approval
    Keam, Susan J.
    DRUGS, 2023, 83 (02) : 181 - 187
  • [5] Population Pharmacokinetics of Nirsevimab in Preterm and Term Infants
    Clegg, Lindsay
    Freshwater, Ed
    Leach, Amanda
    Villafana, Tonya
    Hamren, Ulrika Waehlby
    JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 64 (05) : 555 - 567
  • [6] Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model
    Kieffer, Alexia
    Beuvelet, Matthieu
    Sardesai, Aditya
    Musci, Robert
    Milev, Sandra
    Roiz, Julie
    Lee, Jason K. H.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (SUPPL 2) : S282 - S292
  • [7] Parent Perspectives on Nirsevimab for Their Newborn
    Hinderstein, Sarah
    Aragona, Elena
    Loyal, Jaspreet
    PEDIATRICS, 2024, 154 (06)
  • [8] Nirsevimab and Hospitalization for RSV Bronchiolitis
    Assad, Zein
    Romain, Anne-Sophie
    Aupiais, Camille
    Shum, Mickael
    Schrimpf, Cecile
    Lorrot, Mathie
    Corvol, Harriet
    Prevost, Blandine
    Ferrandiz, Charlene
    Giolito, Anna
    Valtuille, Zaba
    Bendavid, Matthieu
    Cohen, Jeremie F.
    Toubiana, Julie
    de Pontual, Loic
    Delande, Camille F.
    Levy, Michael
    See, Perrine
    Cohen, Robert
    Levy, Corinne
    Angoulvant, Francois
    Lenglart, Lea
    Gits-Muselli, Maud
    Biran, Valerie
    Diallo, Kadiatou
    Alemede, Oluwafunmilola
    El Hebil, Mohamed M.
    Durrmeyer, Xavier
    Labouret, Geraldine
    Casanovas, Natacha
    Hallak, Benjamin
    Marechal, Olympe
    Jung, Camille
    Brehin, Camille
    Ouldali, Naim
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (02) : 144 - 154
  • [9] Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United States
    Gomez, Gabriela B.
    Nelson, Christopher B.
    Rizzo, Christopher
    Shepard, Donald S.
    Chaves, Sandra S.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (SUPPL 2) : S293 - S299
  • [10] Impact of Nirsevimab Immunization on Pediatric Hospitalization Rates: A Systematic Review and Meta-Analysis (2024)
    Ricco, Matteo
    Cascio, Antonio
    Corrado, Silvia
    Bottazzoli, Marco
    Marchesi, Federico
    Gili, Renata
    Giuri, Pasquale Gianluca
    Gori, Davide
    Manzoni, Paolo
    VACCINES, 2024, 12 (06)
12345